Status:
COMPLETED
Awareness, Care & Treatment In Obesity Management - An Observation in Switzerland
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Brief Summary
ACTION Switzerland is a cross-sectional, observational, descriptive, and exploratory survey-based study without collection of laboratory data. The study is not related to any specific treatment option...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- People Living with Obesity:
- Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol).
- Male, female or other, aged above or equal to 18 years at the time of signing informed consent
- Lives in Switzerland (minimum quota based on primary language: German, French and Italian to ensure adequate samples for sub-group analysis)
- Current BMI of 30 Kg/m\^2 or greater calculated based on self-reported height and weight
- Health Care Professionals:
- Informed consent before any study related activities (study-related activities are any procedure related to recording/collection of data according to protocol)
- Male, female or other, aged above or equal to 18 years at the time of signing informed consent.
- Physician
- Dietitian who is a member of the SVDE ASDD (Swiss Association of Dietitians) and services covered by the compulsory health insurance
- Primary Care Providers (PCPs) whose specialty is Family Practice, General Practice, General Internal Medicine (who is focused on primary care)
- Non-PCP Specialties whose specialty is Obstetrics/Gynaecologists, Endocrinologists/Diabetologists. Psychiatrists, General Internal Medicine with focus on diabetes and/or obesity and bariatric surgeons who are involved in the management of obesity in addition to surgery
- Practices in Switzerland
- In clinical practice for greater than or equal to 2 years
- Spends at least 50% time in direct patient care
- Has seen at least 100 adult patients in past month (all physicians except psychiatrists) Has seen at least 10 patients with obesity (PCPs and General Internal Medicine with focus on Diabetes and/or obesity, Obstetrics/ Gynaecologists, Endocrinology/Diabetology or Bariatric surgery) or 5 patients with obesity (dietitians and psychiatrists) in past month needing weight management defined as: a patient with a BMI greater than or equal to 30 Kg/m\^2 with or without comorbidities.
- Exclusion criteria:
- People Living with Obesity:
- Previous participation in this study. Participation is defined as having given online consent in this study
- Currently pregnant
- Participates in intense fitness or body building programs
- Has had significant, unintentional weight loss (due to major injury, illness, etc) in the past 6 months
- Mental incapacity, unwillingness or language barriers precluding adequate understanding or cooperation
- Health Care Providers:
- Previous participation in this study. Participation is defined as having given informed consent in this study.
- Unwillingness, inability, or language barriers precluding adequate understanding or cooperation.
Exclusion
Key Trial Info
Start Date :
March 8 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 8 2022
Estimated Enrollment :
1152 Patients enrolled
Trial Details
Trial ID
NCT05232786
Start Date
March 8 2022
End Date
April 8 2022
Last Update
October 26 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Zurich, Switzerland